Although delivery systems are seemingly designed with beneficial intentions and streamlined utilization, a number of current practices and policies have been the subject of criticism and controversy. Two leaders in health policy shared their insights regarding these concerns and discussed the necessary steps to further improve an antiquated delivery system during changing times.
The second session of the 2012 America’s Health Insurance Plan’s Medicare and Medicaid Conferences on Monday featured a workshop titled “Delivery System Reform: A Look Back, a Look Forward,” led by 2 key speakers representing different policy institutes.
Robert A. Berenson, MD, FACP, a fellow at the Health Policy Center of the Urban Institute, began the presentation with what he described as “head scratchers.” These “head scratchers” covered a wide variety of current practices and policies that have seemingly beneficial intentions, but have actually resulted in, or currently cause, misappropriated resources, under- or overutilization, and mismanagement. The following is a brief list of the controversial practices that Dr Berenson contended should be reformed and remedied to improve the future of the healthcare delivery system:
Dr Berenson was followed by Mark B. McClellan, MD, PhD, the director and chair of health policy studies at the Engelberg Center for Health Care Reform in The Brookings Institute. He elaborated on the current trends of health delivery systems, noting a financial alignment to support increased value and the growth of practical experience, especially outside of integrated health systems. However, because much of the debate surrounding healthcare reform is rooted in further cost management without detracting from the quality of care, he noted that there must be supportive changes in financing and reallocating resources. In addition, there needs to be a capacity for measuring the impact of these reforms at the patient level, and increased leadership to promote communication about further beneficial opportunities, build trust, and implement new interactions across providers and settings that did not previously work together. Creating this novel environment of payer-provider collaboration with patient and consumer involvement, although necessary, will not be easy, Berenson admitted, but with enough momentum and the right support, it can be accomplished.
To learn more about this session, please visit the AHIP 2012 Medicare and Medicaid Conference website.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More